Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10259)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Spalinger MR, McCole DF, Rogler G, Scharl M. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1034-1044 [PMID: 26811645 DOI: 10.3748/wjg.v22.i3.1034] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i3/1034.htm |
| Number | Citing Articles |
| 1 |
Tapan Behl, Amit Gupta, Aayush Sehgal, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi, Saurabh Bhatia, Simona Bungau. Exploring protein tyrosine phosphatases (PTP) and PTP-1B inhibitors in management of diabetes mellitus. Biomedicine & Pharmacotherapy 2022; 153: 113405 doi: 10.1016/j.biopha.2022.113405
|
| 2 |
P. Zhang, W. Zhang, D. Zhang, M. Wang, R. Aprecio, N. Ji, O. Mohamed, Y. Li, Y. Ding, Q. Wang. 25‐Hydroxyvitamin D3‐enhanced PTPN2 positively regulates periodontal inflammation through the JAK/STAT pathway in human oral keratinocytes and a mouse model of type 2 diabetes mellitus. Journal of Periodontal Research 2018; 53(3): 467 doi: 10.1111/jre.12535
|
| 3 |
Shougang Liu, Fanghua Liu, Zeqiao Zhang, Zhe Zhuang, Yongfeng Chen. PTPN2 inhibits the proliferation of psoriatic keratinocytes by dephosphorylation of STAT3. Cell Biochemistry and Function 2024; 42(2) doi: 10.1002/cbf.3947
|
| 4 |
Arianne L. Theiss. Ptpn2: A Critical Regulator of Paneth Cell Homeostasis. Cellular and Molecular Gastroenterology and Hepatology 2023; 16(1): 163 doi: 10.1016/j.jcmgh.2023.03.010
|
| 5 |
Ya Li, Huimin Zhou, Yulin Li, Lu Han, Ming Song, Fangfang Chen, Guokai Shang, Di Wang, Zhihao Wang, Wei Zhang, Ming Zhong. PTPN2 improved renal injury and fibrosis by suppressing STAT‐induced inflammation in early diabetic nephropathy. Journal of Cellular and Molecular Medicine 2019; 23(6): 4179 doi: 10.1111/jcmm.14304
|
| 6 |
Nour Younis, Rana Zarif, Rami Mahfouz. Inflammatory bowel disease: between genetics and microbiota. Molecular Biology Reports 2020; 47(4): 3053 doi: 10.1007/s11033-020-05318-5
|
| 7 |
Morten L Halling, Jens Kjeldsen, Torben Knudsen, Jan Nielsen, Lars Koch Hansen. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World Journal of Gastroenterology 2017; 23(33): 6137-6146 doi: 10.3748/wjg.v23.i33.6137
|
| 8 |
Noelia Cambeiro-Pérez, Claudio Hidalgo-Cantabrana, Marco Antonio Moro-García, Aitor Blanco-Míguez, Florentino Fdez-Riverola, Sabino Riestra, Anália Lourenço, Rebeca Alonso-Arias, Abelardo Margolles, Elena Martínez-Carballo, Borja Sánchez. In silico and functional analyses of immunomodulatory peptides encrypted in the human gut metaproteome. Journal of Functional Foods 2020; 70: 103969 doi: 10.1016/j.jff.2020.103969
|
| 9 |
Xiao-Er Tang, Ya-Qiong Cheng, Chao-Ke Tang. Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1219690
|
| 10 |
Stéphanie Bussières-Marmen, Valérie Vinette, Jeremy Gungabeesoon, Isabelle Aubry, Luis Alberto Pérez-Quintero, Michel L Tremblay. Loss of T-cell protein tyrosine phosphatase in the intestinal epithelium promotes local inflammation by increasing colonic stem cell proliferation. Cellular & Molecular Immunology 2018; 15(4): 367 doi: 10.1038/cmi.2016.72
|
| 11 |
Patricia Teixeira Santana, Siane Lopes Bittencourt Rosas, Beatriz Elias Ribeiro, Ygor Marinho, Heitor S. P. de Souza. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. International Journal of Molecular Sciences 2022; 23(7): 3464 doi: 10.3390/ijms23073464
|
| 12 |
Wan-Chen Hsieh, Mattias N.D. Svensson, Martina Zoccheddu, Michael L. Tremblay, Shimon Sakaguchi, Stephanie M. Stanford, Nunzio Bottini. PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis. JCI Insight 2020; 5(20) doi: 10.1172/jci.insight.141868
|
| 13 |
Yiping Liu, Zhan Ye, Xiang Li, Jennifer L. Anderson, Mike Khan, Douglas DaSilva, Marissa Baron, Deborah Wilson, Vera Bocoun, Lynn C. Ivacic, Steven J. Schrodi, Judith A. Smith. Genetic and Functional Associations with Decreased Anti-inflammatory Tumor Necrosis Factor Alpha Induced Protein 3 in Macrophages from Subjects with Axial Spondyloarthritis. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00860
|
| 14 |
Shuling Fan, Caroline M. Weight, Anny-Claude Luissint, Roland S. Hilgarth, Jennifer C. Brazil, Mark Ettel, Asma Nusrat, Charles A. Parkos, Alpha Yap. Role of JAM-A tyrosine phosphorylation in epithelial barrier dysfunction during intestinal inflammation. Molecular Biology of the Cell 2019; 30(5): 566 doi: 10.1091/mbc.E18-08-0531
|
| 15 |
JOHNNY AWWAD, MIRNA SOUAID, TONY YAMMINE, ALAIN CHEBLY, NABIHA SALEM, RITA ESBER, CHANTAL FARRA. A homozygous missense variant in PTPN2 with early-onset Crohn’s disease, growth failure and dysmorphic features in an infant: a case report. Journal of Genetics 2023; 102(2) doi: 10.1007/s12041-023-01433-x
|
| 16 |
Rajrupa Chakraborty, David D. Lo. Inducible Lymphoid Organs. Current Topics in Microbiology and Immunology 2020; 426: 45 doi: 10.1007/82_2020_208
|
| 17 |
Sharon Tran, Juliani Juliani, W. Douglas Fairlie, Erinna F. Lee. The emerging roles of autophagy in intestinal epithelial cells and its links to inflammatory bowel disease. Biochemical Society Transactions 2023; 51(2): 811 doi: 10.1042/BST20221300
|
| 18 |
Baojin Yao, Mei Zhang, Xiangyang Leng, Meixin Liu, Yuxin Liu, Yaozhong Hu, Daqing Zhao, Yu Zhao. Antler extracts stimulate chondrocyte proliferation and possess potent anti-oxidative, anti-inflammatory, and immune-modulatory properties. In Vitro Cellular & Developmental Biology - Animal 2018; 54(6): 439 doi: 10.1007/s11626-018-0266-2
|
| 19 |
Qingbu Mei, Chang Liu, Xuelong Zhang, Qiuyan Li, Xueyuan Jia, Jie Wu, Wenjing Sun, Yuandong Qiao, Jiawei Wu, Yuzhen Li, Jingcui Yu, Songbin Fu, Lidan Xu. Associations between PTPN2 gene polymorphisms and psoriasis in Northeastern China. Gene 2019; 681: 73 doi: 10.1016/j.gene.2018.09.047
|
| 20 |
Jie Pan, Lisha Zhou, Chenyang Zhang, Qiang Xu, Yang Sun. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01038-3
|
| 21 |
Rihan Wu, Qinyu He, Haitao Chen, Miao Xu, Ning Zhao, Ying Xiao, Qian-qian Tu, Wenjun Zhang, Xiaoying Bi. MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2). Biochemical and Biophysical Research Communications 2017; 486(3): 759 doi: 10.1016/j.bbrc.2017.03.115
|
| 22 |
Mingsong Kang, Alberto Martin. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Seminars in Immunology 2017; 32: 3 doi: 10.1016/j.smim.2017.04.003
|
| 23 |
Ryong Kong, Ok‑Hwa Kang, Yun‑Soo Seo, Tian Zhou, Sang‑A Kim, Dong‑Won Shin, Dong‑Yeul Kwon. MAPKs and NF‑κB pathway inhibitory effect of bisdemethoxycurcumin on phorbol‑12‑myristate‑13‑acetate and A23187‑induced inflammation in human mast cells. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7852
|
| 24 |
Ma Yangchun, Yang WenYu, Zhou Liang, Li LiPeng, Wu JingWei, Li WeiYa, Du Shan, Ma Ying, Wang RunLing. Exploring the cause of the dual allosteric targeted inhibition attaching to allosteric sites enhancing SHP2 inhibition. Molecular Diversity 2022; 26(3): 1567 doi: 10.1007/s11030-021-10286-4
|
| 25 |
Kelly A. Pike, Michel L. Tremblay. Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02504
|
| 26 |
Anna Niechcial, Matthias Butter, Salomon Manz, Nicole Obialo, Katharina Bäbler, Lisa van der Lely, Silvia Lang, Claudia Gottier, Declan F McCole, Michael Scharl, Marianne R Spalinger. Presence of PTPN2 SNP rs1893217 Enhances the Anti-inflammatory Effect of Spermidine. Inflammatory Bowel Diseases 2020; 26(7): 1038 doi: 10.1093/ibd/izaa013
|
| 27 |
Fang-Shu Cheng, Dan Pan, Bing Chang, Min Jiang, Li-Xuan Sang. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World Journal of Clinical Cases 2020; 8(8): 1361-1384 doi: 10.12998/wjcc.v8.i8.1361
|